Lewis W. Coleman, Director at Immune Design Corp. (IMDZ), bought 8,000 shares at $9.15 ($74K) on 2017-07-07, disclosed to the SEC on 2017-07-10.
Open-market purchase of $74k IMDZ by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.39 | 4,000 | $38K | 50.6% |
| 2 | $9.15 | 4,000 | $37K | 49.4% |
| Total | $9.27 avg | 8,000 | $74K | 100% |
| Filing → |
| IMDZ | BUY | 2017-07-12 | $109K | — | Filing → |
| IMDZ | SELL | 2016-12-27 | $62K | — | Filing → |
| IMDZ | BUY | 2016-09-20 | $250K | — | Filing → |